Foligraf 75Iu Injection 0.5 ml

Foligraf 75Iu Injection belongs to a group of medicines called ‘fertility drugs' used to treat infertility. It belongs to the family of hormones called ‘gonadotropins’ that are involved in reproduction and fertility. When a woman cannot become pregnant within a year of trying, then the condition is called female infertility. If a woman gets pregnant but experiences miscarriages or stillbirths, it is also included in infertility. It is also used to treat hypogonadism in men.

Foligraf 75Iu Injection contains ‘Follitropin alfa’, which acts by developing and ripening several follicles (containing an egg) and inducing the ovulation procedure (releasing an egg from the ovary). An egg must be released from the ovary to get fertilised by a sperm cell to get pregnant. In infertile men, Foligraf 75Iu Injection is used along with other medicines to help produce sperm.

You should use this medicine exactly as prescribed by your doctor. The common side-effects of Foligraf 75Iu Injection are headache, ovarian cysts (sacks of fluid within the ovaries), vomiting, diarrhoea, abdominal cramps, and local reactions at the injection site. These side effects are usually mild and temporary. However, inform your doctor immediately if any of these side effects persist or get worse.

Inform your doctor if you have a known allergy to Follitropin alfa or any contents present in it. Foligraf 75Iu Injection is not recommended for women with ovarian cysts, unexplained vaginal bleeding, cancer in ovaries, womb, or breasts that have a tumour. And Foligraf 75Iu Injection is not recommended for males with damaged testicles that cannot be healed. Foligraf 75Iu Injection is not recommended for use in children. Do not use Foligraf 75Iu Injection if you are a pregnant and breastfeeding woman. Foligraf 75Iu Injection may interact with alcohol and worsen your health condition. Foligraf 75Iu Injection may not affect your ability to drive.

Foligraf 75Iu Injection contains ‘Follitropin alfa’ used to treat fertility problems (usually given along with other medicines). It develops and ripens several follicles (containing eggs necessary for fertilization) in women undergoing assisted reproductive technologies (a procedure that helps to get pregnant). It also helps to induce the ovulation procedure (releasing an egg from the ovary) in women who are suffering from anovulation (who cannot produce eggs) and oligo-ovulation (who produce few eggs). Foligraf 75Iu Injection helps to stimulate healthy ovaries for the production of eggs. In males, it helps replenish the deficient testosterone (anabolic steroid and primary sex hormone in males) levels and helps produce sperm cells.

• Headache
• Sacs of fluid within the ovaries (ovarian cysts)
• Abdominal pain
• Diarrhoea
• Pain or redness at the injection site

Foligraf 75Iu Injection may cause ovarian hyperstimulation syndrome (OHSS), a condition in which ovarian follicles develop too much and become large cysts. If you notice abnormal pain, rapid weight gain, difficulty breathing, or feel sick, inform your doctor immediately, as it may be a sign of OHSS. Foligraf 75Iu Injection may increase the risk of multiple pregnancies (pregnant with more than one child at the same time), birth defects, ectopic pregnancy (pregnancy outside the womb), and miscarriage. So, your doctor may advise you to undergo certain blood tests and ultrasounds throughout the treatment to identify if you have developed any above-mentioned risks associated with Foligraf 75Iu Injection . Before taking Foligraf 75Iu Injection , inform your doctor if you have a history of blood clots in the legs, lungs, or heart attack. Foligraf 75Iu Injection may increase the risk of blood clots and worsen your existing clots. Also, inform your doctor if you have undergone multiple regimens for infertility treatment, as Foligraf 75Iu Injection may increase the risk of tumours in the ovaries and other sex organs. Inform your doctor immediately if your skin becomes fragile and easily blistered or if you have stomach, arm, or leg pain after taking Foligraf 75Iu Injection . Foligraf 75Iu Injection is not recommended for women with primary ovarian failure (ovaries no longer produce eggs properly).

Drug-Drug Interactions: Foligraf 75Iu Injection may interact with a medicine used to treat irregular menstrual periods (gonadorelin).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Foligraf 75Iu Injection should not be used in patients with adrenal dysfunction, thyroid dysfunction, ovarian cysts (fluid-filled sacs in ovaries), and tumours of ovaries, womb, or breast.

• GONADORELIN

• Do regular exercise and physical activity. Maintain a healthy weight. Besides this, weight-bearing exercises can help in making your bones strong. Aerobics, yoga, and activities like tai chi may help in relaxing the body and mind.
• Consume a healthy diet, including food rich in antioxidants, fibre-rich foods, and high-fat dairy. Cut down on carbs or limit refined carbs.
• Try to be stress-free to improve your mood swings due to hormonal fluctuations.
• Limit caffeine intake.
• Quit smoking and limit alcohol consumption, as these can be risk factors for female infertility.

If you undergo a pregnancy test (blood or urine test) within 10 days of using Foligraf 75Iu Injection , there may be a chance of a false-positive test result.

Female Infertility: When a woman cannot become pregnant within a year of trying without the use of contraception, then the condition is called female infertility. If a woman gets pregnant but experiences miscarriages or stillbirths, it is also included in infertility. It can occur due to ovulation disorders (problems with ovaries), fallopian tube damage, and uterus or cervix problems. The risk factors can be age, being overweight or obese, smoking, alcoholism, and the presence of sexually transmitted infections.

Hypogonadism: It is a condition in which the gonads (testes in men and ovaries in women) produce insufficient sex hormones. Sex hormones are responsible for secondary sexual characteristics. This mainly occurs due to autoimmune disorders, genetic disorders, severe infections, pituitary disorders, and inflammatory diseases.